| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |